Achieve Life Sciences, Inc.
ACHVNasdaqCIK 949858HealthcareFiscal year ends Dec 31
Reports and events: 327 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0120:49 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-410781 |
| 2026-08-1420:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-352229 |
| 2026-08-1120:09 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-344624 |
| 2026-08-1120:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-344571 |
| 2026-07-0620:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-296174 |
| 2026-06-0820:06 ET | DEF 14A | Proxy statementPeriod 2026-06-08 | 0000949858-26-000006 |
| 2026-06-0212:51 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-252624 |
| 2026-05-1211:21 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-218177 |
| 2026-05-1211:20 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-218175 |
| 2026-04-3020:20 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001193125-26-197402 |
| 2026-04-2721:28 ET | SCHEDULE 13D | Ownership report, active investor | 0000905148-26-001871 |
| 2026-04-2421:03 ET | SCHEDULE 13D | Ownership report, active investor | 0001999371-26-009036 |
| 2026-04-1620:47 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-159189 |
| 2026-03-2411:10 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-120690 |
| 2026-03-2411:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-120687 |
| 2025-11-0612:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-268074 |
| 2025-11-0612:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-268056 |
| 2025-10-0720:51 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-233581 |
| 2025-09-1121:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-201418 |
| 2025-08-0711:40 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-104571 |
| 2025-08-0711:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104569 |
| 2025-06-2721:28 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-091055 |
| 2025-06-0620:53 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-083214 |
| 2025-05-1311:38 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-069806 |
| 2025-05-1311:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069804 |
| 2025-04-2820:09 ET | DEF 14A | Proxy statementPeriod 2025-04-28 | 0000950170-25-059297 |
| 2025-03-1111:37 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-036831 |
| 2025-03-1111:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-036830 |
| 2025-02-1021:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-017068 |
| 2025-01-1014:26 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-003873 |
| 2024-12-0921:23 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-134558 |
| 2024-11-0721:15 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123375 |
| 2024-11-0721:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123334 |
| 2024-09-2720:55 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-110066 |
| 2024-08-2620:39 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001193125-24-207129 |
| 2024-08-1320:08 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-096193 |
| 2024-08-1320:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-096171 |
| 2024-07-2912:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-24-087118 |
| 2024-06-2720:10 ET | 8-K | 7.01 Regulation FD disclosure | 0000950170-24-078445 |
| 2024-06-0621:07 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-069973 |
| 2024-05-0920:08 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-056929 |
| 2024-05-0920:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056876 |
| 2024-04-2620:05 ET | DEF 14A | Proxy statementPeriod 2024-06-05 | 0000950170-24-049089 |
| 2024-03-2820:14 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-038049 |
| 2024-03-2820:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-038030 |
| 2024-02-2921:41 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-023189 |
| 2023-12-1121:04 ET | 8-K | 8.01 Other events | 0000950170-23-069392 |
| 2023-11-0921:08 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062028 |
| 2023-11-0921:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062005 |
| 2023-08-1420:09 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-042401 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:01 ET. Listed shows no prices and gives no investment advice.